semaglutide non responders GLP-1 nonresponders: Up to 1 in 5 people don't lose weight Semaglutide Non-Response: Why Some Don't

Patients should be aware that the online marketplace for weight loss products is poorly regulated in some jurisdictions

JMIR Res

Tirzepatide is a dual-agonist , meaning it works by targeting two hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Retatrutide is a triple-agonist , meaning it targets three hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Glucagon: affects energy use and fat metabolism Early studies show that retatrutide may be more successful than tirzepatide at managing diabetic kidney disease, as well as for weight control, while tirzepatide may be better at managing blood glucose

This is not a rejection of GLP-1s

Another common effect is a loss of skin tone - that Ozempic face, butt, and breasts

Seek medical attention if you experience severe abdominal pain that radiates to your back (possible pancreatitis), persistent vomiting that causes dehydration, yellowing of the skin or eyes, significant changes in urine output, or any signs of an allergic reaction